Stemson Therapeutics Raises $15M in Series A Funding
- Stemson Therapeutics, a San Diego, CA-based pre-clinical stage cell therapy company, closed a $15m Series A financing
- The round was led by DCVC Bio with participation from Genoa Ventures, AbbVie Ventures and other investors
- The company intends to use the funds to advance development of its proprietary therapeutic solution to cure hair loss
- Stemson Therapeutics is a pre-clinical stage cell therapy company with a mission to cure hair loss by leveraging the regenerative power of Induced Pluripotent Stem Cell (iPSC)
- The company uses iPSC to regenerate the critical cells required to grow hair and which are damaged or depleted in patients suffering from hair loss
- The iPSC-derived cells are used to grow de novo hair follicles, offering a new supply of hair to treat people suffering from various forms of Alopecia
